Vall Hebron Research Institute

Vall Hebron Research Institute
Paseo Vall Hebron, 119-129
08035 Barcelona

Lead Investigator

Dr. Joan Montaner
Team leader
+34 934894073
+34 934894015

Project Staff

Dr. Anna Rosell
Senior researcher
+34 934894029
+34 934894015

Dr. Alejandro Bustamante
+34 934894029
+34 934894015

Dr. Iván Cristobo
Project Manager
+34 934894399
+34 934894015

Ms. Anna Penalba
Laboratory technician
+34 934894399
+34 934894015

Mrs. Natalia Corbeto
Laboratory and financial Manager
+34 934894029
+34 934894015

Institute Presentation


Vall d'Hebron Research Institute (VHIR) is a public sector institution that promotes and develops innovative biomedical research and the University Hospital Vall d'Hebron. VHIR is oriented towards finding solutions to the health problems of the citizens and has the will to contribute to the scientific, educational, social and economic development within its area of competence.


We want that our research and innovation, carried out by the people who make up the institution, expands the frontiers of knowledge and becomes an active and important reference for our society, our health system and its citizens, attracting talent and ensuring that our business in terms of excellence, quality and translation, corresponds to the leading position that the Hospital Vall d'Hebron must have.


  • Professional excellence, of different training profiles and origins. The importance of clinical and investigative environment in the research groups' configuration has to be stressed.  This value is enhanced by a critical mass of clinical professionals.
  • Recognized scientific excellence and prestige at a national and European scope, which is reflected on the progressive improvement of its recent results.
  • Privileged position for interaction between third level healthcare-research-teaching
  • Competitiveness and efficiency to advance in the evolution of the institute toward a research park 
  • Universality, promoting the internationalization of its activity
  • Public Service, research as an integrated public policy to transfer benefits to citizens
  • Innovation Capacity, evolution toward a knowledge-based organization

Barcelona and its metropolitan surroundings are already a focus of biomedical research. In this context, the presence of institutions such as hospitals that focus their research activity on solving important human health problems is essential. The University Hospital Vall d’Hebron and its Research Institute aspire to be one of the main actors to help define and consolidate this space of biomedical research in southern Europe; working both in basic and translational or applied research. It has the challenge to promote and resolutely support clinical research.

Our new facilities have to improve the quality and the enviroment of clinical trials and research. We encourage all medical and heathcare levels. We work for medical students, medical residents or nursing personnel to have more opportunities to join quality biomedical research. The new Central Unit for Clinical Research and Clinical Essays (UCICAC) and the Clinical Research Committee (CEIC) must have a central role in this dynamization.

We have created new units and structures to adapt ourselves to modern times. We have also increased the space dedicated to research, which is a capital advance. The new modular building for research is located at the highest part of the hospital grounds -Collserola Building. It has recently been opened to expand the different research spaces, it has 2.500 m2 of new space, which are dedicated to new laboratories.

We are working to achieve a direct translation from research to applications. Our research is focused on solving human health problems and on healthcare improvement. At the same time, we resolutely encourage the tasks of valuation and transfer of research results to the industry and biomedical companies. Innovation is the core of our activity, not only understood as processes of innovation, information technologies' innovation or knowledge in biomedical research transfer, but innovation derived from the incorporation of new technologies and from daily healthcare practice. Undoubtedly, we have a large way to go and a great opportunity to achieve a leadership position in our area of influence.

This is an exciting project to develop in the next years with the help of all professionals that work at the University Hospital and at the Research Institute. It is an opportunity to keep on improving research and healthcare quality for the benefit of our society, for which we work.

The Neurovascular Research Group (LIN)

Neurovascular Research Lab was created in 2001 focused in stroke research from a basic and translational point of view. Dr. Joan Montaner directed the creation of the lab and nowadays is composed by a young and highly motivated group of researchers:  neurologists,  biologists,  technicians, veterinarians,  graduates in statistics, psychologists and nurses.

The research we are carrying out in our lab is reflected in the number of published articles in high impact factor publications and the attendance and presentation of our work in international congresses as the American Stroke Conference or the European Stroke Conference, among others.

The Work in our lab is divided into six lines of research:

  • Biomarkers
  • Prevention
  • Neurorepair
  • Acute treatment
  • Amyloid